Nicholas N. Vahanian

2017

In 2017, Nicholas N. Vahanian earned a total compensation of $3M as President at NewLink Genetics, a 33% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$184,200
Option Awards$2,192,081
Salary$552,212
Other$53,546
Total$2,982,039

Vahanian received $2.2M in option awards, accounting for 74% of the total pay in 2017.

Vahanian also received $184.2K in non-equity incentive plan, $552.2K in salary and $53.5K in other compensation.

Rankings

In 2017, Nicholas N. Vahanian's compensation ranked 3,660th out of 14,666 executives tracked by ExecPay. In other words, Vahanian earned more than 75.0% of executives.

ClassificationRankingPercentile
All
3,660
out of 14,666
75th
Division
Manufacturing
1,262
out of 5,772
78th
Major group
Chemicals And Allied Products
355
out of 2,075
83rd
Industry group
Drugs
273
out of 1,731
84th
Industry
Pharmaceutical Preparations
216
out of 1,333
84th
Source: SEC filing on April 9, 2018.

Vahanian's colleagues

We found four more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2017.

2017

Charles Link

NewLink Genetics

Chief Executive & Scientific Officer

2017

John Henneman

NewLink Genetics

Chief Financial Officer

2017

Eugene Kennedy

NewLink Genetics

Chief Medical Officer

2017

Brian Wiley

NewLink Genetics

Chief Commercial Officer

News

In-depth

You may also like